Want to see XNCR full AI Analyst Report?

Xencor (XNCR) Stock Forecast & Price Target

362 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

XNCR Analyst Ratings

Strong Buy

9 Buy

2 Hold

0 Sell

Based on 11 analysts giving stock ratings to

Xencor

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

XNCR Stock 12 Month Forecast

Average Price Target

$28.25

▲(45.32% Upside)

Based on 11 Wall Street analysts offering 12 month price targets for Xencor in the last 3 months. The average price target is $28.25 with a high forecast of $44.00 and a low forecast of $14.00. The average price target represents a 45.32% change from the last price of $19.44.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"6":"$6","45":"$45","15.75":"$15.75","25.5":"$25.5","35.25":"$35.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":44,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$44.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":28.25,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$28.25</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":14,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$14.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[6,15.75,25.5,35.25,45],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Nov<br/>2025","6":"Feb<br/>2026","9":"May<br/>2026","12":"Aug<br/>2026","25":"Aug<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,20.21,22.04,23.87,25.7,27.53,29.36,31.189999999999998,33.019999999999996,34.85,36.68,38.51,40.34,42.17,{"y":44,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,20.21,20.82846153846154,21.446923076923078,22.065384615384616,22.683846153846154,23.302307692307693,23.92076923076923,24.53923076923077,25.157692307692308,25.776153846153846,26.394615384615385,27.013076923076923,27.63153846153846,{"y":28.25,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,20.21,19.732307692307693,19.254615384615384,18.776923076923076,18.29923076923077,17.821538461538463,17.343846153846155,16.866153846153846,16.388461538461538,15.910769230769231,15.433076923076923,14.955384615384617,14.477692307692308,{"y":14,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":7.98,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":8.55,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":11.83,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":14.71,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":16.51,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":15.31,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":12.11,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":12.3,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":12.53,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":12.69,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":11.8,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":15.38,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":20.21,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$44.00

Average Price Target$28.25

Lowest Price Target$14.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Alec Stranahan

Bank of America Securities

$17→$20

Hold

2.88%

Upside

Reiterated

08/07/26

Xencor (XNCR) Receives a Hold from Bank of America Securities

Etzer Darout

Barclays

$27

Buy

38.89%

Upside

Reiterated

08/06/26

Analysts Offer Insights on Healthcare Companies: Xencor (NASDAQ: XNCR), Alpha Teknova (NASDAQ: TKNO) and Solventum Corporation (NYSE: SOLV)

David Nierengarten

Wedbush

$26→$30

Buy

54.32%

Upside

Reiterated

08/06/26

Xencor price target raised to $30 from $26 at WedbushXencor price target raised to $30 from $26 at Wedbush

Gregory Renza

Truist Financial

―

Buy

―

Reiterated

08/06/26

Analysts' Opinions Are Mixed on These Healthcare Stocks: GoodRx Holdings (NASDAQ: GDRX), Xencor (NASDAQ: XNCR) and PepGen Inc. (NASDAQ: PEPG)

Steven Seedhouse

Cantor Fitzgerald

$43→$44

Buy

126.34%

Upside

Reiterated

08/06/26

Xencor price target raised to $44 from $43 at Cantor FitzgeraldXencor price target raised to $44 from $43 at Cantor Fitzgerald

Matt Phipps

William Blair

―

Buy

―

Reiterated

08/06/26

Xencor Earns Buy Rating as XmAb541 and XmAb808 Advance Toward Differentiated Solid-Tumor Franchise

Edward Tenthoff

Piper Sandler

$33

Buy

69.75%

Upside

Reiterated

08/06/26

Piper Sandler Remains a Buy on Xencor (XNCR)

Leonid Timashev

RBC Capital

$19→$20

Buy

2.88%

Upside

Reiterated

08/05/26

RBC Capital Sticks to Their Buy Rating for Xencor (XNCR)

Tara Bancroft

TD Cowen

―

Buy

―

Reiterated

08/05/26

Xencor: Buy Rating Backed by XmAb819 Expansion and Immunology Pipeline Milestones Ahead of Key 2026–2027 Data Catalysts

John Newman

Canaccord Genuity

$38

Buy

95.47%

Upside

Reiterated

08/05/26

Analyst John Newman Reiterates Buy on Xencor, Citing Late-Stage XmAb Pipeline, Non-Dilutive Cash Inflows and Royalties, and Sets $38 Price Target

Brian Cheng

J.P. Morgan

$13→$14

Hold

-27.98%

Downside

Assigned

05/11/26

Xencor price target raised to $14 from $13 at JPMorganXencor price target raised to $14 from $13 at JPMorgan

Unknown Analyst

Wells Fargo

Not Ranked

Wells Fargo

$27

Buy

38.89%

Upside

Reiterated

05/07/26

Xencor (XNCR) Receives a Buy from Wells Fargo

Unknown Analyst

Roth MKM

Not Ranked

Roth MKM

Sell

-69.14%

Downside

Initiated

09/17/25

Xencor (XNCR) Receives a Sell from Roth MKM

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Alec Stranahan

Bank of America Securities

$17→$20

Hold

2.88%

Upside

Reiterated

08/07/26

Xencor (XNCR) Receives a Hold from Bank of America Securities

Etzer Darout

Barclays

$27

Buy

38.89%

Upside

Reiterated

08/06/26

Analysts Offer Insights on Healthcare Companies: Xencor (NASDAQ: XNCR), Alpha Teknova (NASDAQ: TKNO) and Solventum Corporation (NYSE: SOLV)

David Nierengarten

Wedbush

$26→$30

Buy

54.32%

Upside

Reiterated

08/06/26

Xencor price target raised to $30 from $26 at WedbushXencor price target raised to $30 from $26 at Wedbush

Gregory Renza

Truist Financial

―

Buy

―

Reiterated

08/06/26

Analysts' Opinions Are Mixed on These Healthcare Stocks: GoodRx Holdings (NASDAQ: GDRX), Xencor (NASDAQ: XNCR) and PepGen Inc. (NASDAQ: PEPG)

Steven Seedhouse

Cantor Fitzgerald

$43→$44

Buy

126.34%

Upside

Reiterated

08/06/26

Xencor price target raised to $44 from $43 at Cantor FitzgeraldXencor price target raised to $44 from $43 at Cantor Fitzgerald

Matt Phipps

William Blair

―

Buy

―

Reiterated

08/06/26

Xencor Earns Buy Rating as XmAb541 and XmAb808 Advance Toward Differentiated Solid-Tumor Franchise

Edward Tenthoff

Piper Sandler

$33

Buy

69.75%

Upside

Reiterated

08/06/26

Piper Sandler Remains a Buy on Xencor (XNCR)

Leonid Timashev

RBC Capital

$19→$20

Buy

2.88%

Upside

Reiterated

08/05/26

RBC Capital Sticks to Their Buy Rating for Xencor (XNCR)

Tara Bancroft

TD Cowen

―

Buy

―

Reiterated

08/05/26

Xencor: Buy Rating Backed by XmAb819 Expansion and Immunology Pipeline Milestones Ahead of Key 2026–2027 Data Catalysts

John Newman

Canaccord Genuity

$38

Buy

95.47%

Upside

Reiterated

08/05/26

Analyst John Newman Reiterates Buy on Xencor, Citing Late-Stage XmAb Pipeline, Non-Dilutive Cash Inflows and Royalties, and Sets $38 Price Target

Brian Cheng

J.P. Morgan

$13→$14

Hold

-27.98%

Downside

Assigned

05/11/26

Xencor price target raised to $14 from $13 at JPMorganXencor price target raised to $14 from $13 at JPMorgan

Unknown Analyst

Wells Fargo

Not Ranked

Wells Fargo

$27

Buy

38.89%

Upside

Reiterated

05/07/26

Xencor (XNCR) Receives a Buy from Wells Fargo

Unknown Analyst

Roth MKM

Not Ranked

Roth MKM

Sell

-69.14%

Downside

Initiated

09/17/25

Xencor (XNCR) Receives a Sell from Roth MKM

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

AVBPArriVent BioPharma, Inc.

BTSGBrightSpring Health Services, Inc.

AMLXAmylyx Pharmaceuticals Inc

TNYATenaya Therapeutics

JBIOJade Biosciences

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Xencor

3 Months

Gregory RenzaTruist Financial

Success Rate

9/20 ratings generated profit

Average Return

-2.63%

Copying Gregory Renza's trades and holding each position for 3 Months would result in 45.00% of your transactions generating a profit, with an average return of -2.63% per trade.

1 Year

John NewmanCanaccord Genuity

Success Rate

8/12 ratings generated profit

Average Return

+19.13%

Copying John Newman's trades and holding each position for 1 Year would result in 66.67% of your transactions generating a profit, with an average return of +19.13% per trade.

2 Years

John NewmanCanaccord Genuity

Success Rate

9/12 ratings generated profit

Average Return

+43.73%

Copying John Newman's trades and holding each position for 2 Years would result in 75.00% of your transactions generating a profit, with an average return of +43.73% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

XNCR Analyst Recommendation Trends

Rating

Apr 26

May 26

Jun 26

Jul 26

Aug 26

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, XNCR has received 16 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. XNCR average Analyst price target in the past 3 months is 28.25.

Each month's total comprises the sum of three months' worth of ratings.

XNCR Financial Forecast

XNCR Earnings Forecast

Next quarter’s earnings estimate for XNCR is -$0.32 with a range of -$1.04 to $0.22. The previous quarter’s EPS was -$0.29. XNCR beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.44% of the time in the same period. In the last calendar year XNCR has Performed in-line its overall industry.

XNCR Sales Forecast

Next quarter’s sales forecast for XNCR is $60.42M with a range of $10.00M to $115.20M. The previous quarter’s sales results were $51.22M. XNCR beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.34% of the time in the same period. In the last calendar year XNCR has Performed in-line its overall industry.

XNCR Stock Forecast FAQ

What is XNCR’s average 12-month price target, according to analysts?

Based on analyst ratings, Xencor Inc.’s 12-month average price target is 28.25.

What is XNCR’s upside potential, based on the analysts’ average price target?

Xencor Inc. has 45.32% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is XNCR a Buy, Sell or Hold?

Xencor Inc. has a consensus rating of Strong Buy which is based on 9 buy ratings, 2 hold ratings and 0 sell ratings.

What is Xencor Inc.’s price target?

The average price target for Xencor Inc. is 28.25. This is based on 11 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $44.00 ,the lowest forecast is $14.00. The average price target represents 45.32% Increase from the current price of $19.44.

What do analysts say about Xencor Inc.?

Xencor Inc.’s analyst rating consensus is a Strong Buy. This is based on the ratings of 11 Wall Streets Analysts.

How can I buy shares of XNCR?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Xencor (XNCR) Stock Forecast & Price Target

XNCR Analyst Ratings

XNCR Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Xencor

XNCR Analyst Recommendation Trends

XNCR Financial Forecast

XNCR Earnings Forecast

XNCR Sales Forecast

XNCR Stock Forecast FAQ

Detailed List of Analyst Forecasts